Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use

Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use

US Patent 11203756 · Granted Dec 21, 2021

Estimated economic value: $90,490,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Determining frequency offset of signal under test2025
RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
5′-cyclo-phosphonate modified nucleotides2025
RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), 2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions there2025
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions there2025
Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin2025
Alpha-v beta-6 integrin ligands and uses thereof2024